Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy
Sponsor: Children's Hospital Colorado
A EARLY_PHASE1 clinical study on Developmental and Epileptic Encephalopathy and STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder, this trial is ongoing. The trial is conducted by Children's Hospital Colorado and has accumulated 11 data snapshots since 2021. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting EARLY_PHASE1
-
Oct 2025 — Feb 2026 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Enrolling By Invitation → Active Not Recruiting
-
Feb 2025 — Oct 2025 [monthly]
Enrolling By Invitation EARLY_PHASE1
-
Sep 2024 — Feb 2025 [monthly]
Enrolling By Invitation EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation EARLY_PHASE1
▶ Show 6 earlier versions
-
Nov 2023 — Jul 2024 [monthly]
Enrolling By Invitation EARLY_PHASE1
Status: Active Not Recruiting → Enrolling By Invitation
-
Feb 2023 — Nov 2023 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Oct 2022 — Feb 2023 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jun 2022 — Oct 2022 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2022 — Jun 2022 [monthly]
Recruiting EARLY_PHASE1
-
Sep 2021 — Apr 2022 [monthly]
Recruiting EARLY_PHASE1
First recorded
Mar 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Colorado
- Clara Inspired
- Horizon Therapeutics
- SLC6A1 Connect
- STXBP1 Foundation
- University of Pennsylvania Orphan Disease Center
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .